Diindolylmethane

Diindolylmethane has been used in trials studying the prevention and treatment of SLE, Prostate Cancer, Cervical Dysplasia, Stage I Prostate Cancer, and Stage II Prostate Cancer, among others. The directory classifies it as a commercial API with a natural source/manufacturing origin. Other names for this substance include Plant Indole and Infemin. Its PubChem CID is 3071.

CAS No 1968-05-4
Molecular Formula C17H14N2
Molecular Weight 246.31 g/mol
Synonyms 3-(1H-indol-3-ylmethyl)-1H-indole

Frequently Asked Questions